#Coronavirus Disease Research #References (by AMEDEO, March 22 '25)

 

Ann Intern Med

1. 
   Correction: Anticoagulation Among Patients Hospitalized for COVID-19.
   Ann Intern Med. 2025 Mar 18. doi: 10.7326/ANNALS-25-00916.
   PubMed        
   
   

   
   Antiviral Res

2. SAFIRIYU AA, Hussain A, Dewangan N, Kasle G, et al
   The fusion peptide of the spike protein S2 domain may be a mimetic analog of beta-coronaviruses and serve as a novel virus-host membrane fusion inhibitor.
   Antiviral Res. 2025 Mar 16:106144. doi: 10.1016/j.antiviral.2025.106144.
   PubMed         Abstract available
   
   
3. XU M, Zhang Z, Sun Y, Mai H, et al
   Corrigendum to "IgA class switching enhances neutralizing potency against SARS-CoV-2 by increased antibody hinge flexibility" [Antiv. Res. (2025) 106082].
   Antiviral Res. 2025 Mar 20:106146. doi: 10.1016/j.antiviral.2025.106146.
   PubMed        
   
   

   
   Graefes Arch Clin Exp Ophthalmol

4. ZUREIK A, Couturier A, Delcourt C
   Evolution of ophthalmological care in adult with diabetes in France between 2010 and 2022: a nationwide study.
   Graefes Arch Clin Exp Ophthalmol. 2025 Mar 17. doi: 10.1007/s00417-025-06793.
   PubMed         Abstract available
   
   

   
   Int J Infect Dis

5. LASTRUCCI V, Pacifici M, Puglia M, Alderotti G, et al
   Recent trends in hospitalizations for Respiratory Syncytial Virus after the COVID-19 pandemic and before routine immunization: seasonality and severity updates from the 2023/2024 season in Tuscany, Italy.
   Int J Infect Dis. 2025 Mar 13:107879. doi: 10.1016/j.ijid.2025.107879.
   PubMed         Abstract available
   
   

   
   Intensive Care Med

6. CHEN B, Li S
   Optimizing non-intubated respiratory support in COVID-19: evaluating the impact of bundle of care strategy on awake prone positioning tolerance.
   Intensive Care Med. 2025 Mar 17. doi: 10.1007/s00134-025-07860.
   PubMed        
   
   

   
   Invest Radiol

7. SONG J, Hwang EJ, Yoon SH, Park CM, et al
   Emerging Trends and Innovations in Radiologic Diagnosis of Thoracic Diseases.
   Invest Radiol. 2025 Mar 20. doi: 10.1097/RLI.0000000000001179.
   PubMed         Abstract available
   
   

   
   J Infect

8. PEREZ CM, Ruiz-Rius S, Ramirez-Morros A, Vidal M, et al
   Post-vaccination IgG4 and IgG2 class switch associates with increased risk of SARS-CoV-2 infections.
   J Infect. 2025 Mar 18:106473. doi: 10.1016/j.jinf.2025.106473.
   PubMed         Abstract available
   
   

   
   J Med Virol

9. BOTELLO-MARABOTTO M, Tarraso J, Mulet A, Presa-Fernandez L, et al
   Metabolomic Biomarkers of Pulmonary Fibrosis in COVID-19 Patients One Year After Hospital Discharge.
   J Med Virol. 2025;97:e70289.
   PubMed         Abstract available
   
   
10. VENTUROLI S, Bertoldi A, Manaresi E, Lazzarotto T, et al
    Epidemiology of Parvovirus B19 Infection In an Italian Metropolitan Area, 2012-2024: COVID-19 Pre-Pandemic, Pandemic and Post-Pandemic Trends.
    J Med Virol. 2025;97:e70296.
    PubMed         Abstract available
    
    
11. FOURGEAUD J, Turlure P, Dupont M, Veyrenche N, et al
    Remdesivir for the Treatment of Human Coronavirus OC43 Encephalitis.
    J Med Virol. 2025;97:e70314.
    PubMed         Abstract available
    
    
12. AMEGASHIE EA, Kwayisi-Darkwah CK, Adusei-Poku M, Sikeola RO, et al
    Lipid Peroxidation and Glutathione Levels Among People Living With HIV Co-infected With Human Coronaviruses in Ghana.
    J Med Virol. 2025;97:e70301.
    PubMed         Abstract available
    
    

    
    J Virol

13. ZHONG Q, Qi J, Su N, Li Z, et al
    In vivo investigation of PEDV transmission via nasal infection: mechanisms of CD4(+) T-cell-mediated intestinal infection.
    J Virol. 2025 Mar 17:e0176124. doi: 10.1128/jvi.01761.
    PubMed         Abstract available
    
    
14. SIMS A, Weir DJ, Cole SJ, Hutchinson E, et al
    SARS-CoV-2 cellular coinfection is limited by superinfection exclusion.
    J Virol. 2025 Mar 21:e0207724. doi: 10.1128/jvi.02077.
    PubMed         Abstract available
    
    
15. BEAVIS AC, Li Z, Briggs K, Gingerich MC, et al
    Efficacy of parainfluenza virus 5 (PIV5)-vectored intranasal COVID-19 vaccine as a single dose primer and booster against SARS-CoV-2 variants.
    J Virol. 2025 Mar 21:e0198924. doi: 10.1128/jvi.01989.
    PubMed         Abstract available
    
    
16. BEAVIS AC, Xiao P, Gingerich MC, Briggs K, et al
    A parainfluenza virus 5 (PIV5)-vectored intranasal SARS-CoV-2 vaccine (CVXGA1) elicits protective and long-lasting immunity in nonhuman primates.
    J Virol. 2025 Mar 21:e0199024. doi: 10.1128/jvi.01990.
    PubMed         Abstract available
    
    

    
    Lancet Infect Dis

17. RAMOS B, Vadlamudi NK, Han C, Sadarangani M, et al
    Future immunisation strategies to prevent Streptococcus pneumoniae infections in children and adults.
    Lancet Infect Dis. 2025 Mar 17:S1473-3099(24)00740.
    PubMed         Abstract available
    
    
18. HASLAM E
    Lessons from the COVID-19 pandemic.
    Lancet Infect Dis. 2025 Mar 13:S1473-3099(25)00177.
    PubMed        
    
    

    
    Nature

19. MERKENSCHLAGER J, Pyo AGT, Silva Santos GS, Schaefer-Babajew D, et al
    Regulated somatic hypermutation enhances antibody affinity maturation.
    Nature. 2025 Mar 19. doi: 10.1038/s41586-025-08728.
    PubMed         Abstract available
    
    

    
    Travel Med Infect Dis

20. RODRIGUEZ-MORALES AJ, Puerta-Arias MC, Husni R, Montenegro-Idrogo JJ, et al
    Infectious Diseases Prevention and Vaccination in migrants in Latin America: The challenges of transit through the treacherous Darien Gap, Panama.
    Travel Med Infect Dis. 2025 Mar 18:102839. doi: 10.1016/j.tmaid.2025.102839.
    PubMed        
    
    
21. SRIVASTAVA S, Sharma D, Sridhar SB, Kumar S, et al
    HKU5-CoV-2: A silent threat looming in bats.
    Travel Med Infect Dis. 2025;65:102838.
    PubMed